Ubrogepant: First Approval

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

(2020) Wendy Ankrom et al.   CTS-Clinical and Translational Science

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

(2020) Jessica Ailani et al.   HEADACHE

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults

(2019) Peter J Goadsby et al.   CEPHALALGIA

Recent Advances in Pharmacotherapy for Episodic Migraine

(2019) Calvin Chan et al.   CNS DRUGS

Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries

(2019) Eloísa Rubio-Beltran et al.   CEPHALALGIA

Making Better Dose Decisions: Using Exposure‐Response Modeling to Integrate Efficacy Outcome of Two Phase 2b Clinical Trials of Ubrogepant for Migraine Treatment

(2019) Chi‐Chung Li et al.   CTS-Clinical and Translational Science

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine

(2019) Richard B. Lipton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial

(2019) Abhijeet Jakate et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Ubrogepant for the Treatment of Migraine

(2019) David W. Dodick et al.   NEW ENGLAND JOURNAL OF MEDICINE

CGRP as the target of new migraine therapies — successful translation from bench to clinic

(2018) Lars Edvinsson et al.   Nature Reviews Neurology

Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy

(2018) Philip R. Holland et al.   Neurotherapeutics

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

(2016) Tiffini Voss et al.   CEPHALALGIA